XOMA (STU:X0M1) Institutional Ownership : 24.27% (As of Jun. 09, 2024)

View and export this data going back to 1986. Start your Free Trial

What is XOMA Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, XOMA's institutional ownership is 24.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, XOMA's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, XOMA's Float Percentage Of Total Shares Outstanding is 68.36%.

XOMA Institutional Ownership Historical Data

The historical data trend for XOMA's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Institutional Ownership Chart

XOMA Historical Data

The historical data trend for XOMA can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	25.78	25.82	23.42	23.52	23.62	23.62	23.25	24.42	24.32	24.27

XOMA Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

XOMA (STU:X0M1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Corp (STU:X0M1) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMAP.PFD:USA XOMA:USA X0M1:Germany

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

XOMA (STU:X0M1) Headlines

No Headlines